• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Indonesian Digital Derma Startup Diri Care Scores $4.3M in Seed Funding

Share:

August 16, 2022

Medical technology concept.

Diri Care, a consumer health technology startup based in Jakarta, Indonesia has snapped up $4.3 million in a seed funding round led by East Ventures and Surge, a rapid scale-up program for startups by Sequoia Capital India and Southeast Asia.

WHAT IT DOES

Diri Care, which translates to “self-care” in Bahasa, is a digital clinic for skin, hair, and sexual health concerns. Established early this year, it offers online health assessments by certified physicians, personalized treatment prescriptions, and same-day product delivery.

Since launching a beta web platform earlier in March, the startup has facilitated more than 13,000 consultations. It plans to release a mobile app version on Android and iOS devices “in the near future”.

WHAT IT’S FOR

According to a press statement, the seed funding will go to efforts in expanding Diri Care’s offerings to customers across Indonesia, as well as enhancing its platform’s technological capability.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Diri Care is eyeing Indonesia’s beauty and personal care market, which is seen to hit $9.6 billion in value by 2025.

MARKET SNAPSHOT

Budding Indonesian health tech startups have attracted seed funding in recent months. In February, personal health coaching app Sirka received $2.6 million in seed funding, which it plans to use for conducting research and establishing partnerships with medical advisors. Last month, insurtech firm ​​Rey Assurance also secured seed funding worth $4.2 million.

Meanwhile in the Asia-Pacific dermatology space, CureSkin, an AI-powered skincare app in India recently closed a $5 million Series A funding round. Another AI-enabled derma platform, Clinikally, launched in India in May.

ON THE RECORD

“Diri Care marries technology and medical science to inspire authentic confidence and well-being for modern consumers. We believe everyone deserves affordable, high-quality, patient-centric care, and Diri Care is leading the way in democratizing that access for everyone, everywhere, for good,” said CEO and co-founder Christian Suwarna.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • New Organization Fostering AI, Automation and HealthcareNew Organization Fostering AI, Automation and Healthcare
  • Pharmacies Take Up Drug Disposal Effort Big Pharma has FoughtPharmacies Take Up Drug Disposal Effort Big Pharma has Fought
  • Abscess Pipeline Insight Market COVID19 OUTBREAK Impact | Overview, History, Trends, Key Companies, Patent Detail, Acquisition, Collaboration, Deal Value, Stages and Targets and Development Activities Analysis Research ReportAbscess Pipeline Insight Market COVID19 OUTBREAK Impact | Overview, History, Trends, Key Companies, Patent Detail, Acquisition, Collaboration, Deal Value, Stages and Targets and Development Activities Analysis Research Report
  • Conduent Completes Acquisition of Health Solutions Plus to Provide Core Administrative Processing TechnologyConduent Completes Acquisition of Health Solutions Plus to Provide Core Administrative Processing Technology
  • Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical BusinessAlcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
  • Smiths Medical parent co to announce separation plans FridaySmiths Medical parent co to announce separation plans Friday
  • LianBio Partners with Landos to Commercialize Colitis, Crohn’s Drugs in ChinaLianBio Partners with Landos to Commercialize Colitis, Crohn’s Drugs in China
  • Livongo Expands Partnership with Blue Cross and Blue Shield of Kansas CityLivongo Expands Partnership with Blue Cross and Blue Shield of Kansas City

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications